AR

Akash Rajput

Active Director Director DIN 09555876
DIN 09555876 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value •••• Premium profile

About Akash Rajput

Data last updated:

Akash Rajput is a Director at Caxton Biotech Private Limited (since 2022). The company operates in Chemicals. Caxton Biotech Private Limited reported revenue of ₹75.6 Lakh (FY 2024).

DIN 09555876
Primary Designation Director
Industry Chemicals
First Appointment 31 Mar 2022
Oldest Company Age 4 yrs
Largest company Caxton Biotech Private Limited · ₹75.6 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Caxton Biotech Private Limited U24290CH2022PTC044285
Director31 Mar 20222022₹75.6 Lakh (FY 2024)Active

Board colleagues of Akash Rajput

NameDINCompanyDesignation
Krishan Kumar09555877Caxton Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Caxton Biotech Private Limited
Premium access

Shareholding and investment profile for Akash Rajput

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Rajput

Akash Rajput currently holds 1 directorship: Caxton Biotech Private Limited (Director, since 31 Mar 2022, revenue ₹75.6 Lakh (FY 2024)).

Akash Rajput was first appointed on 31 Mar 2022 as Director at Caxton Biotech Private Limited.

The current boards of Akash Rajput's companies include Krishan Kumar (Caxton Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available